Quiero saber acerca de...

lotter on DSK11XQN23PROD with NOTICES1

60262

Federal Register / Vol. 86, No. 208 / Monday, November 1, 2021 / Notices
Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD 20892, 301 806
0009, Jacinta.bronte-tinkew@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel;
Fellowships: AIDS and HIV related applications.
Date: December 3, 2021.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Kristen Prentice, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 20892, 301 496
0726, prenticekj@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR20
104: Biomedical Technology Development and Dissemination BTDD Center.
Date: December 9, 2021.
Time: 9:30 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: James J. Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301806
8065, lijames@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Visual Neuroscience.
Date: December 9, 2021.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Brian H. Scott, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 301
8277490, brianscott@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; AIDS and AIDS Related Research.
Date: December 10, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Alok Mulky, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4203, Bethesda, MD 20892, 301 4353566, mulkya@mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, 93.337, 93.39393.396, 93.83793.844,
VerDate Sep<11>2014

18:03 Oct 29, 2021

Jkt 256001

93.84693.878, 93.892, 93.893, National Institutes of Health, HHS
Dated: October 26, 2021.
David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202123697 Filed 102921; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
AGENCY:

The Department of Health and Human Services HHS notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities IITFs currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine or Oral Fluid Mandatory Guidelines.
FOR FURTHER INFORMATION CONTACT:
Anastasia Donovan, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N06B, Rockville, Maryland 20857; 240276
2600 voice; Anastasia.Donovan@
samhsa.hhs.gov email.
SUPPLEMENTARY INFORMATION: In accordance with Section 9.19 of the Mandatory Guidelines, a notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF
certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines.
If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program NLCP
during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter.
This notice is also available on the internet at https www.samhsa.gov/
workplace/resources/drug-testing/
certified-lab-list.
The Department of Health and Human Services HHS notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities IITFs SUMMARY:

PO 00000

Frm 00065

Fmt 4703

Sfmt 4703

currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs Mandatory Guidelines using Urine and of the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
The Mandatory Guidelines using Urine were first published in the Federal Register on April 11, 1988 53
FR 11970, and subsequently revised in the Federal Register on June 9, 1994 59
FR 29908; September 30, 1997 62 FR
51118; April 13, 2004 69 FR 19644;
November 25, 2008 73 FR 71858;
December 10, 2008 73 FR 75122; April 30, 2010 75 FR 22809; and on January 23, 2017 82 FR 7920.
The Mandatory Guidelines using Oral Fluid were first published in the Federal Register on October 25, 2019
84 FR 57554 with an effective date of January 1, 2020.
The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503
of Public Law 10071 and allowed urine drug testing only. The Mandatory Guidelines using Urine have since been revised, and new Mandatory Guidelines allowing for oral fluid drug testing have been published. The Mandatory Guidelines require strict standards that laboratories and IITFs must meet in order to conduct drug and specimen validity tests on specimens for federal agencies. HHS does not allow IITFs to conduct oral fluid testing.
To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance testing program plus undergo periodic, on-site inspections.
Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS
Mandatory Guidelines using Urine and/
or Oral Fluid. An HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA
formerly: HHS/NIDA, which attests that the test facility has met minimum standards. HHS does not allow IITFs to conduct oral fluid testing.
HHS-Certified Laboratories Approved To Conduct Oral Fluid Drug Testing In accordance with the Mandatory Guidelines using Oral Fluid dated October 25, 2019 84 FR 57554, the following HHS-certified laboratories meet the minimum standards to conduct drug and specimen validity tests on oral fluid specimens:

E:FRFM01NON1.SGM

01NON1